Key Takeaways
- • The Competition Commission of India (CCI) has cleared Advent International affiliate Rasmalai Ltd's proposed Rs 3,150 crore primary investment in Yatharth Hospital & Trauma Care Services Limited, according to Moneycontrol.
- • The transaction would give Advent a 24.9% minority stake in the listed Noida-based hospital chain once completed.
- • The CCI announced the approval in a post on X on Tuesday, November 10, 2026.
- • The capital is intended to fund Yatharth's expansion and strengthen its network across India.
- • Yatharth reported a 17.45% rise in consolidated net profit to Rs 48.45 crore for the September quarter, with revenue from operations at Rs 431.42 crore.
Summary
The Competition Commission of India has approved private equity firm Advent International's proposed investment in Yatharth Hospital & Trauma Care Services Limited, clearing the way for a Rs 3,150 crore capital infusion into the listed healthcare provider. The investment is being made through Advent's affiliate Rasmalai Ltd, an entity incorporated in Cyprus that holds investments and currently has no activities or presence in India. Following completion, Advent is expected to hold a 24.9% minority stake in the company.
The CCI said on Tuesday that it had approved the acquisition of a shareholding in Yatharth by Rasmalai, posting the announcement on X. Deals above certain thresholds require the regulator's clearance, which is intended to guard against unfair business practices and promote fair competition. The approval follows the September announcement by Yatharth that Advent had entered into a definitive agreement to invest Rs 3,150 crore of primary capital in the company.
According to the company, the proceeds will provide growth capital to fund Yatharth's expansion plans and strengthen its healthcare network across the country. The transaction also allows Advent to expand its footprint in India's fast-growing hospital and healthcare services market.
Founded in 2008, Yatharth is among North India's fastest-growing listed healthcare providers. It operates nine multi-speciality hospitals with 2,800 beds and an overall announced capacity of 3,250 beds, offering super-speciality care, diagnostics and advanced medical procedures. Earlier in November, the company reported a 17.45% rise in consolidated net profit to Rs 48.45 crore for the September quarter, up from Rs 41.25 crore a year earlier. Revenue from operations rose to Rs 431.42 crore, according to the company.
The CCI said on Tuesday that it had approved the acquisition of a shareholding in Yatharth by Rasmalai, posting the announcement on X. Deals above certain thresholds require the regulator's clearance, which is intended to guard against unfair business practices and promote fair competition. The approval follows the September announcement by Yatharth that Advent had entered into a definitive agreement to invest Rs 3,150 crore of primary capital in the company.
According to the company, the proceeds will provide growth capital to fund Yatharth's expansion plans and strengthen its healthcare network across the country. The transaction also allows Advent to expand its footprint in India's fast-growing hospital and healthcare services market.
Founded in 2008, Yatharth is among North India's fastest-growing listed healthcare providers. It operates nine multi-speciality hospitals with 2,800 beds and an overall announced capacity of 3,250 beds, offering super-speciality care, diagnostics and advanced medical procedures. Earlier in November, the company reported a 17.45% rise in consolidated net profit to Rs 48.45 crore for the September quarter, up from Rs 41.25 crore a year earlier. Revenue from operations rose to Rs 431.42 crore, according to the company.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.